Bibliographic Details
| Title: |
Who Benefits Most from Adjuvant Durvalumab after Chemoradiotherapy for Non-Small Cell Lung Cancer? |
| Authors: |
Ohri, N.1 (AUTHOR), Halmos, B.2 (AUTHOR), Bodner III, W.R.1 (AUTHOR), Cheng, H.2 (AUTHOR), Garg, M.K.1 (AUTHOR), Gucalp, R.2 (AUTHOR), Guha, C.1 (AUTHOR) |
| Source: |
International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pe85-e86. 2p. |
| Subjects: |
Non-small-cell lung carcinoma, Chemoradiotherapy, Rectal cancer |
| Database: |
Engineering Source |
